2015
Three patients, in whom tumour overkill by cytotoxic treatment, including high dose methotrexate with folinic acid rescue, resulted in the 'phosphate shower syndrome' (hyper-uricaemia, hyperkalaemia and hyperphosphataemia with hypocalcaemia and tetany, with metabolic acidosis and acute renal impairment) are described.
 Three patients: Subject; Three: Subject.Population; 'phosphate shower syndrome' (hyper-uricaemia, hyperkalaemia and hyperphosphataemia with hypocalcaemia and tetany, with metabolic acidosis and acute renal impairment): Effect; cytotoxic treatment, including high dose methotrexate with folinic acid rescue: Treatment; tumour: Treatment.Disorder; cytotoxic: Treatment.Drug; methotrexate: Treatment.Drug; folinic acid rescue: Treatment.Drug; high dose: Treatment.Dosage; folinic acid rescue: Combination.Drug; methotrexate: Combination.Drug; cytotoxic: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 Three patients: Subject; Three: Subject.Population; 'phosphate shower syndrome' (hyper-uricaemia, hyperkalaemia and hyperphosphataemia with hypocalcaemia and tetany, with metabolic acidosis and acute renal impairment): Effect; cytotoxic treatment, including high dose methotrexate with folinic acid rescue: Treatment; tumour: Treatment.Disorder; cytotoxic: Treatment.Drug; methotrexate: Treatment.Drug; folinic acid rescue: Treatment.Drug; high dose: Treatment.Dosage; folinic acid rescue: Combination.Drug; methotrexate: Combination.Drug; cytotoxic: Combination.Drug